Ovarian NeoplasmsEarly Detection of CancerMammographyUterine Cervical NeoplasmsMass ScreeningMedically UninsuredBreast NeoplasmsVaginal SmearsUnited StatesNeoplasms, Glandular and EpithelialSensitivity and SpecificityEarly DiagnosisTumor Markers, BiologicalCA-125 AntigenPolymerase Chain ReactionCell Line, TumorProstatic NeoplasmsGene Expression Regulation, NeoplasticCystadenocarcinoma, SerousLung NeoplasmsGenes, BRCA1Neoplasm InvasivenessPrognosisNeoplasmsCarcinomaReproducibility of ResultsMice, NudeLimit of DetectionNeoplasm StagingNeoplasm ProteinsAntineoplastic AgentsNeoplasm MetastasisReverse Transcriptase Polymerase Chain ReactionColonic NeoplasmsDrug Resistance, NeoplasmStomach NeoplasmsGenetic Predisposition to DiseaseSurvival AnalysisPancreatic NeoplasmsProspective StudiesRetrospective StudiesMutationSurvival RateCisplatinGene Expression ProfilingRisk FactorsDisease ProgressionAntineoplastic Combined Chemotherapy ProtocolsGenes, BRCA2Follow-Up StudiesPaclitaxelRNA, MessengerPredictive Value of TestsXenograft Model Antitumor AssaysNeoplasm Recurrence, LocalDNA, NeoplasmColorectal NeoplasmsRiskCancer VaccinesBRCA2 ProteinTime FactorsCarcinoma, Squamous CellDNA MethylationRisk AssessmentBlotting, WesternBRCA1 ProteinAdenocarcinoma, Clear CellEnzyme-Linked Immunosorbent AssayOligonucleotide Array Sequence AnalysisAdenocarcinoma, MucinousAge FactorsDisease-Free SurvivalEndometrial NeoplasmsGenotypePeritoneal NeoplasmsBase SequenceTumor Cells, CulturedMolecular Sequence DataCarcinoma, EndometrioidRegistriesUrinary Bladder NeoplasmsImmunohistochemistryNeoplasm TransplantationAntigens, NeoplasmGerm-Line MutationAdenocarcinomaProstate-Specific AntigenGenetic TestingAntineoplastic Agents, PhytogenicCell ProliferationCarcinoma, Non-Small-Cell LungImmunoenzyme TechniquesROC CurveAntibodies, MonoclonalOdds RatioNational Cancer Institute (U.S.)DNA PrimersRNA, Small InterferingApoptosisEpididymal Secretory Proteins